AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
136 hedge funds and large institutions have $437M invested in Aerie Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
25% less call options, than puts
Call options by funds: $123K | Put options by funds: $163K
Holders
136
Holding in Top 10
–
Calls
$123K
Puts
$163K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$9.09M | |
| 3 | +$9.01M | |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$5.63M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.32M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$8.04M | |
| 3 | -$7.48M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.55M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$3.9M |